Investigational Site Number : 250001

Paris 75908

1 studies enrolling now · 13 studies all time

What they study most

Acute Lymphocytic Leukaemia, Arrhythmia Prophylaxis, Asthma, Glycogen Storage Disease Type II, Hematopoietic Neoplasm, Pompe Disease, Prostate Cancer, Retinitis Pigmentosa, Sphingomyelin Lipidosis, Stargardt's Disease, Systemic Sclerosis, Usher Syndrome

Studies at this site

• Pompe Disease Registry Protocol — Recruiting now
• A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B — Running, not enrolling
• Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration — Running, not enrolling
• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed
• Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency — Completed
• SAR3419 in Acute Lymphoblastic Leukemia — Stopped early
• Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B — Stopped early
• Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration — Stopped early
• Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis — Completed
• Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death — Completed
• Proof of Biological Activity of SAR100842 in Systemic Sclerosis — Completed